Market Tracker

03/30 4:21pm ET

GlaxoSmithKline PLC (NYSE:GSK)

42.48
Delayed Data
As of 4:02pm ET
 -0.25 / -0.59%
Today’s Change
37.20
Today|||52-Week Range
45.58
+10.31%
Year-to-Date
Here Are "The Most Profitable Corporations You've Never Heard Of"
8:37am / Investing Channel - Paid Partner Content
Why Google Has to Definitively Address Its Offensive Content Problem
Mar 23 / TheStreet.com - Paid Partner Content
VBI Vaccines Emerges as Strong Biotech Stock
Mar 29 / TheStreet.com - Paid Partner Content
Pernix: An Investor's Rationale to Staying Long
Mar 23 / GuruFocus News - Paid Partner Content
GlaxoSmithKline Continues to Strengthen
Mar 29 / TheStreet.com - Paid Partner Content
Novartis' Acute Heart Failure Drug Fails in Late-Stage Study
Mar 22 / Zacks.com - Paid Partner Content
J&J (JNJ) Anaemia Drug Marketing Label Expanded in Europe
Mar 27 / Zacks.com - Paid Partner Content
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar 21 / Zacks.com - Paid Partner Content
Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma
Mar 27 / Zacks.com - Paid Partner Content
6 Reasons to Invest in GlaxoSmithKline (GSK) Stock in 2017
Mar 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close42.73
Today’s open42.74
Day’s range42.37 - 42.76
Volume2,619,111
Average volume (3 months)3,519,112
Market cap$105.1B
Dividend yield4.72%
Data as of 4:02pm ET, 03/30/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+8.85%
Earnings growth (next 5 years)+11.22%
Revenue growth (last year)+2.85%
P/E ratio114.2
Price/Sales2.52
Price/Book74.88

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.31-0.47%
CELGCelgene+0.25+0.20%
SNYSanofi-0.42-0.93%
LLYEli Lilly and Co+0.32+0.38%
Data as of 4:02pm ET, 03/30/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts